Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSE
3051
DELISTED
Trinseo
TSE
| $407K | ﹤0.01% |
176,217
+130,020
| +281% | +$405K |
|
|
SEI
3052
Solaris Energy Infrastructure
SEI
$3.55B
| $407K | ﹤0.01% |
47,439
-11,649
| -20% | -$102K |
|
3053
First Bank
FRBA
$454M
| $406K | ﹤0.01% |
31,860
-6,164
| -16% | -$75.4K |
|
3054
VanEck Pharmaceutical ETF
PPH
$938M
| $406K | ﹤0.01% |
4,436
+605
| +16% | +$54K |
|
3055
Hackett Group
HCKT
$287M
| $405K | ﹤0.01% |
18,655
-13,088
| -41% | -$290K |
|
|
IAS
3056
DELISTED
Integral Ad Science
IAS
| $404K | ﹤0.01% |
41,600
-201,461
| -83% | -$1.93M |
|
|
THR
3057
DELISTED
Thermon Group Holdings
THR
| $404K | ﹤0.01% |
13,140
-17,058
| -56% | -$547K |
|
|
RYZ
3058
Ryerson Holding Corp
RYZ
$1.46B
| $404K | ﹤0.01% |
20,726
-17,962
| -46% | -$463K |
|
3059
Shoals Technologies Group
SHLS
$1.5B
| $404K | ﹤0.01% |
64,686
-838,962
| -93% | -$6.69M |
|
3060
Archer Aviation
ACHR
$4.26B
| $403K | ﹤0.01% |
114,583
-65,535
| -36% | -$243K |
|
3061
Pixelworks
PXLW
$41.6M
| $403K | ﹤0.01% |
34,180
-14,846
| -30% | -$264K |
|
3062
Digi International
DGII
$3.1B
| $403K | ﹤0.01% |
17,584
-18,745
| -52% | -$503K |
|
3063
Kelly Services Class A
KELYA
$527M
| $403K | ﹤0.01% |
18,827
-21,500
| -53% | -$488K |
|
3064
Fate Therapeutics
FATE
$326M
| $403K | ﹤0.01% |
122,888
-201,355
| -62% | -$881K |
|
|
BASE
3065
DELISTED
Couchbase
BASE
| $403K | ﹤0.01% |
22,047
-13,278
| -38% | -$309K |
|
3066
Perimeter Solutions
PRM
$5.77B
| $400K | ﹤0.01% |
51,068
-83,646
| -62% | -$625K |
|
3067
Worthington Steel
WS
$1.95B
| $399K | ﹤0.01% |
11,967
-42,874
| -78% | -$1.4M |
|
3068
Schrodinger
SDGR
$1.36B
| $399K | ﹤0.01% |
20,621
-30,150
| -59% | -$695K |
|
3069
TriMas Corp
TRS
$1.44B
| $398K | ﹤0.01% |
15,589
-22,289
| -59% | -$586K |
|
3070
MGP Ingredients
MGPI
$375M
| $398K | ﹤0.01% |
5,345
-25,957
| -83% | -$2.03M |
|
3071
Safe Bulkers
SB
$774M
| $397K | ﹤0.01% |
68,292
-24,361
| -26% | -$131K |
|
|
MFA
3072
MFA Financial
MFA
$933M
| $397K | ﹤0.01% |
37,339
-54,716
| -59% | -$589K |
|
|
ACH
3073
Accendra Health
ACH
$214M
| $397K | ﹤0.01% |
29,397
-54,590
| -65% | -$1.12M |
|
|
SAFE
3074
Safehold
SAFE
$1.15B
| $397K | ﹤0.01% |
20,562
-24,417
| -54% | -$469K |
|
3075
Allogene Therapeutics
ALLO
$694M
| $397K | ﹤0.01% |
170,228
+13,481
| +9% | +$39.8K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.